External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Timo F W SoeterikTom A HuetingBas IsraëlHarm H E van MelickLea M DijksmanSaskia StompsDouwe H BiesmaHendrik KoffijbergMichiel SedelaarJ Alfred WitjesJean-Paul A van BastenPublished in: BJU international (2021)
T-stage as assessed by mpMRI is an appropriate alternative for T-stage assessed by DRE to determine nomogram-based risk of LNI in patients with prostate cancer, and was associated with improved model performance of both the MSKCC 2018 and Briganti 2012 nomograms.